Gallacher Capital Management »

Halozyme Therapeutics shares owned by Gallacher Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Gallacher Capital Management from 13F filings

Historical chart of Gallacher Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Gallacher Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Gallacher Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $242k 4.2k 57.24
2024-06-30 $375k 7.2k 52.36
2024-03-31 $376k 9.2k 40.68
2023-12-31 $422k 11k 36.96
2023-09-30 $235k 6.2k 38.20

More positions owned by Gallacher Capital Management

Pepsi (PEP)
Cassava Sciences Call Option (SAVA)
Alps Etf Tr Smith Core Plus (SMTH)
Yum! Brands (YUM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Apple (AAPL)
Ishares Msci Emrg Chn (EMXC)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
J P Morgan Exchange Traded F Income Etf (JPIE)

View all positions for Gallacher Capital Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Bank of America Corporation
Arrowpoint Asset Management
Goldman Sachs Group
Handelsbanken Fonder AB
Congress Asset Management
Invesco

View all funds holding Halozyme Therapeutics